A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Part of paid clinical trials in California City, California.
- Sponsor
- BioMarin Pharmaceutical
- Study ID
- NCT06382155
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Idiopathic Short Stature
Eligibility Criteria
- Sex
- ALL
- Age
- 3 Years - 11 Years
- Healthy Volunteers
- Not accepted
Interventions
- Vosoritide Injection — DRUGExperimental Drug Lyophilized powder for reconstitution
- Human Growth Hormone — DRUGCommercial product containing somatotropin
- Placebo — DRUGLyophilized powder for reconstitution
Study Details
The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH)(hGH; only in the United States), in children with idiopathic short stature (ISS).
Key Dates
- Start date
- Oct 21, 2024
- Status verified
- May 2026
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2036
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Vosoritide Dose 1 - Low DoseVosoritide Dose 1 daily injection
- Experimental: Vosoritide Dose 2 - Medium DoseVosoritide Dose 2 daily injection
- Experimental: Vosoritide Dose 3 - High DoseVosoritide Dose 3 daily injection
- Placebo Comparator: PlaceboPlacebo daily injection
- Active Comparator: Human Growth HormonehGH daily injection (US only)
Primary Outcome Measure
Change from baseline in Annualized Growth Velocity (AGV) [ Time Frame: At 6 months ]
Central Contacts
- Trial Specialist+1 415.475.5852
Locations (35)
Find similar trials in California City, CA
By research site
Children's Hospital of Orange County Main Campus - Orange· California City, CAConsano Clinical Research, LLC· California City, CARady Children's Hospital - San Diego· California City, CAChildren's Hospital Los Angeles· Los Angeles, CAChildren's Hospital Oakland Research Institute· Oakland, CACenter Of Excellence in Diabetes and Endocrinology· Sacramento, CA
Related Studies
- A Study to Assess Growth in Children With Idiopathic Short StatureRecruiting · BioMarin Pharmaceutical · Phoenix, Arizona
- Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersPHASE3 · Recruiting · Ascendis Pharma A/S · Sacramento, California